Roche has bolstered its R&D pipeline in oncology and neuroscience with a pair of partnerships with Orionis Biosciences and PeptiDream, parting with upfront cash of $87 million for projects in the ...

Beta is critical to WACC calculations, where it helps 'weight' the cost of equity by accounting for risk. WACC is calculated as: WACC = (weight of equity) x (cost of equity) + (weight of debt ...

Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...

After hours: March 25 at 7:35:11 PM EDT Loading Chart for RIGL ...